Molecular insights into the biased signaling mechanism of the μ-opioid receptor

Mol Cell. 2021 Oct 21;81(20):4165-4175.e6. doi: 10.1016/j.molcel.2021.07.033. Epub 2021 Aug 24.

Abstract

GPCR functional selectivity opens new opportunities for the design of safer drugs. Ligands orchestrate GPCR signaling cascades by modulating the receptor conformational landscape. Our study provides insights into the dynamic mechanism enabling opioid ligands to preferentially activate the G protein over the β-arrestin pathways through the μ-opioid receptor (μOR). We combine functional assays in living cells, solution NMR spectroscopy, and enhanced-sampling molecular dynamic simulations to identify the specific μOR conformations induced by G protein-biased agonists. In particular, we describe the dynamic and allosteric communications between the ligand-binding pocket and the receptor intracellular domains, through conserved motifs in class A GPCRs. Most strikingly, the biased agonists trigger μOR conformational changes in the intracellular loop 1 and helix 8 domains, which may impair β-arrestin binding or signaling. The findings may apply to other GPCR families and provide key molecular information that could facilitate the design of biased ligands.

Keywords: GPCR; NMR; biased agonism; molecular dynamics; opioid.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Analgesics, Opioid / chemistry
  • Analgesics, Opioid / pharmacology*
  • Animals
  • Binding Sites
  • Computer-Aided Design
  • Drug Design
  • Drug Partial Agonism
  • HEK293 Cells
  • Humans
  • Ligands
  • Magnetic Resonance Spectroscopy*
  • Mice
  • Molecular Dynamics Simulation*
  • Protein Binding
  • Protein Interaction Domains and Motifs
  • Protein Stability
  • Receptors, Opioid, mu / agonists
  • Receptors, Opioid, mu / genetics
  • Receptors, Opioid, mu / metabolism
  • Sf9 Cells
  • Signal Transduction / drug effects*
  • Structure-Activity Relationship
  • beta-Arrestins / genetics
  • beta-Arrestins / metabolism

Substances

  • Analgesics, Opioid
  • Ligands
  • Receptors, Opioid, mu
  • beta-Arrestins